U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5691156911Flapless Esthetic Crown Lengthening for the Treatment of Excessive Gingival DisplayCompletedNo Results AvailableGingival OvergrowthProcedure: Open-flap|Procedure: Flaplesshttps://ClinicalTrials.gov/show/NCT01821157
5691256912A School-based Education Programme to Reduce Salt Intake in Children and Their FamiliesRecruitingNo Results AvailableHealthy VolunteerBehavioral: Salt reduction|Other: Controlhttps://ClinicalTrials.gov/show/NCT01821144
5691356913Flax Muffins and Cholesterol LoweringActive, not recruitingNo Results AvailableAbove Optimal Plasma LDL ConcentrationsOther: muffinhttps://ClinicalTrials.gov/show/NCT01821131
5691456914Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid AngiopathyActive, not recruitingNo Results AvailableCerebral Amyloid AngiopathyBiological: Ponezumab|Other: placebohttps://ClinicalTrials.gov/show/NCT01821118
56915569152 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal CancerCompletedNo Results AvailableRecurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV A Bladder Cancer|Stage IV A Rectal Cancer|Stage IV B Colon Cancer|Stage IV B Rectal CancerProcedure: PET Scan|Procedure: CT Scan|Radiation: fludeoxyglucose F 18|Procedure: computer-aided detection/diagnosishttps://ClinicalTrials.gov/show/NCT01821105
5691656916Dimensional Changes of Peri-implant Facial BoneActive, not recruitingNo Results AvailableJaw, Edentulous, PartiallyProcedure: implant insertion and abutment connection|Device: osseointegrated implanthttps://ClinicalTrials.gov/show/NCT01821092
5691756917A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet FormulationCompletedNo Results AvailableHealthyDrug: PF-05175157|Drug: PF-05175157|Drug: PF-05175157|Drug: PF-05175157https://ClinicalTrials.gov/show/NCT01821079
5691856918A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: PD-0332991 alone|Drug: Tamoxifen 60 mg|Drug: Tamoxifen 20 mg|Drug: PD-0332991 combinationhttps://ClinicalTrials.gov/show/NCT01821066
5691956919Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes MellitusRecruitingNo Results AvailablePreeclampsia|Type 1 Diabeteshttps://ClinicalTrials.gov/show/NCT01821053
5692056920A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMRTerminatedNo Results AvailablePolymyalgia RheumaticaDrug: Lodotra®|Drug: Prednisone IR (immediate release)https://ClinicalTrials.gov/show/NCT01821040
5692156921A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Simvastatin|Drug: Canagliflozin (JNJ-28431754)https://ClinicalTrials.gov/show/NCT01821027
5692256922Satellite-supplementation of Medical Outreach Clinics: a Feasibility StudyCompletedNo Results AvailableTelemedicine|Primary Health Care|Developing Countries|Diagnosis|TherapeuticsOther: Telemedicine|Other: In-person physician interactionhttps://ClinicalTrials.gov/show/NCT01821014
5692356923Vaginal Bromocriptine for Treatment of AdenomyosisActive, not recruitingNo Results AvailableAdenomyosisDrug: Vaginal Bromocriptinehttps://ClinicalTrials.gov/show/NCT01821001
5692456924MaSS - Maastricht Sarcopenia StudyActive, not recruitingNo Results AvailableSarcopeniahttps://ClinicalTrials.gov/show/NCT01820988
5692556925Manipulation of Dietary Protein and the Anabolic ResponseCompletedNo Results AvailableFocus: Anabolic Response to Food Intake in Young Individuals.|Condition Relevance: Skeletal Muscle Health, Sarcopenia.Dietary Supplement: High protein mealshttps://ClinicalTrials.gov/show/NCT01820975
5692656926Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological PatientsTerminatedNo Results AvailableHematological Malignancies|Bacteremia|ThrombosisProcedure: heparin|Procedure: concentrated citratehttps://ClinicalTrials.gov/show/NCT01820962
5692756927Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical PatientsCompletedNo Results AvailableSurgeryhttps://ClinicalTrials.gov/show/NCT01820949
5692856928A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765CompletedNo Results AvailableHealthy VolunteersDrug: Sequence 1: PCI-32765|Drug: Sequence 2: PCI-32765|Drug: Sequence 3: PCI-32765|Drug: Sequence 4: PCI-32765|Drug: Sequence 5: PCI-32765https://ClinicalTrials.gov/show/NCT01820936
5692956929Transcranial Brain Stimulation in Vegetative State PatientsCompletedNo Results AvailableVegetative State|Minimally Conscious StateDevice: Transcranial direct current stimulation (tDCS)|Device: Repetitive Transcranial Magnetic Stimulation (rTMS)|Device: Transcranial Direct Current Stimulation (SHAM)|Device: Repetitive Transcranial Magnetic Stimulation (SHAM)https://ClinicalTrials.gov/show/NCT01820923
5693056930This is a Phase 2 Trial of First-line Doxycycline to Treat Ocular Adnexal Marginal Zone LymphomaRecruitingNo Results AvailableMarginal Zone Lymphoma of Ocular AdnexalDrug: Doxycyclinehttps://ClinicalTrials.gov/show/NCT01820910
5693156931Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney TransplantationCompletedNo Results AvailableUrinary Tract Infection|Asymptomatic Bacteriuria|Allograft Rejection|Microbiologic Resistance|HospitalizationDrug: Fosfomycin-Trometamol|Drug: Sulfamethoxazole trimethoprimhttps://ClinicalTrials.gov/show/NCT01820897
5693256932The Safety of Ovarian Preservation in Stage IA Endometrial CarcinomaRecruitingNo Results AvailableEndometrial NeoplasmsProcedure: TH|Procedure: TH/BSO|Procedure: BPLNDhttps://ClinicalTrials.gov/show/NCT01820884
5693356933Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)CompletedNo Results AvailableType 2 Diabetes MellitusOther: Self-Management Using Smartphone Application for Type2 DM|Other: self-management using booklet for management type 2 DMhttps://ClinicalTrials.gov/show/NCT01820871
5693456934The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial CarcinomaRecruitingNo Results AvailableEndometrial NeoplasmsDrug: Paclitaxel|Drug: Paraplatin (Carboplatin Injection)|Radiation: Pelvic Radiation|Radiation: Vaginal Brachytherapy 1|Radiation: Vaginal brachytherapy 2https://ClinicalTrials.gov/show/NCT01820858
5693556935Accuracy of Pleth Variability Index (PVI) in ChildrenCompletedNo Results AvailableScoliosishttps://ClinicalTrials.gov/show/NCT01820845
5693656936Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKDNot yet recruitingNo Results AvailableChronic Kidney Disease|ProteinuriaDrug: Calcitriolhttps://ClinicalTrials.gov/show/NCT01820832
5693756937Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?Active, not recruitingNo Results AvailableInpatient With End Stage Liver Diseasehttps://ClinicalTrials.gov/show/NCT01820819
5693856938Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: 100 mg dose of [14C] GLPG0634https://ClinicalTrials.gov/show/NCT01820806
5693956939Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia ColiActive, not recruitingNo Results AvailableAcute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.ColiDrug: Cefoxitinhttps://ClinicalTrials.gov/show/NCT01820793
5694056940Early Care After Discharge of HF PatientsRecruitingNo Results AvailableHeart FailureOther: Natriuretic peptides levels to J7 and J14|Other: Consultations specialized to J7 and J14|Other: Phone calls in 6 months and 12 months|Other: Natriuretic peptides levels at 6 months|Other: Consultation with the general doctor or the cardiologist to J30 with blood resultshttps://ClinicalTrials.gov/show/NCT01820780

* Görseller ve İçerik tekif hakkına sahip olabilir